May 8 (Reuters) - The U.S. Food and Drug Administration has approved Partner Therapeutics' drug for adults with a rare form of bile duct ‌cancer as part of a new fast-track review program, the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results